Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Astera Labs (ALAB) EBT Margin (2023 - 2025)

Historic EBT Margin for Astera Labs (ALAB) over the last 3 years, with Q3 2025 value amounting to 29.0%.

  • Astera Labs' EBT Margin rose 272200.0% to 29.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 20.74%, marking a year-over-year increase of 474900.0%. This contributed to the annual value of 20.64% for FY2024, which is 8200.0% down from last year.
  • Per Astera Labs' latest filing, its EBT Margin stood at 29.0% for Q3 2025, which was up 272200.0% from 26.4% recorded in Q2 2025.
  • Over the past 5 years, Astera Labs' EBT Margin peaked at 29.0% during Q3 2025, and registered a low of 150.24% during Q2 2023.
  • Moreover, its 3-year median value for EBT Margin was 1.78% (2024), whereas its average is 26.46%.
  • In the last 5 years, Astera Labs' EBT Margin crashed by -251100bps in 2024 and then soared by 1368400bps in 2025.
  • Quarter analysis of 3 years shows Astera Labs' EBT Margin stood at 21.17% in 2023, then crashed by -64bps to 7.58% in 2024, then surged by 282bps to 29.0% in 2025.
  • Its EBT Margin was 29.0% in Q3 2025, compared to 26.4% in Q2 2025 and 13.62% in Q1 2025.